Jove
Visualize
Contact Us

Related Experiment Videos

Medicare drugs.

John A Poisal1

  • 1jpoisal@cms.hhs.gov

Health Care Financing Review
|May 6, 2004
PubMed
Summary

This overview examines prescription drug issues within the Medicare Program, focusing on cost management, cost estimation, and racial disparities in drug coverage and use to inform policy and administration.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

National Health Expenditure Projections, 2025-34: Strong Utilization Growth Initially, Legislative Impacts Later.

Health affairs (Project Hope)·2026
Same author

National Health Expenditure Projections, 2024-33: Despite Insurance Coverage Declines, Health To Grow As Share Of GDP.

Health affairs (Project Hope)·2025
Same author

National Health Expenditure Projections, 2023-32: Payer Trends Diverge As Pandemic-Related Policies Fade.

Health affairs (Project Hope)·2024
Same author

National Health Expenditure Projections, 2022-31: Growth To Stabilize Once The COVID-19 Public Health Emergency Ends.

Health affairs (Project Hope)·2023
Same author

National Health Expenditure Projections, 2021-30: Growth To Moderate As COVID-19 Impacts Wane.

Health affairs (Project Hope)·2022
Same author

National Health Expenditure Projections, 2019-28: Expected Rebound In Prices Drives Rising Spending Growth.

Health affairs (Project Hope)·2020
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Health Policy
  • Pharmaceutical Economics
  • Health Disparities

Background:

  • The Medicare Program faces significant challenges in managing prescription drug benefits.
  • Understanding drug costs and coverage is crucial for beneficiaries and program sustainability.

Purpose of the Study:

  • To synthesize current research on prescription drug issues within Medicare.
  • To explore strategies for drug cost management and estimation.
  • To investigate racial disparities in drug coverage and utilization.

Main Methods:

  • Review of a collection of articles focusing on Medicare prescription drug issues.
  • Analysis of commentaries on private-sector drug benefit administration.
  • Examination of models for estimating drug take-up rates and costs.
  • In-depth analysis of racial disparities across various chronic conditions.

Main Results:

  • Articles address private-sector experiences in administering drug benefits.
  • Models for estimating drug take-up rates and associated costs are presented.
  • Significant racial disparities in drug coverage and use among Medicare beneficiaries are highlighted.

Conclusions:

  • Effective drug cost management and accurate cost estimation are vital for Medicare.
  • Addressing racial disparities in drug access and utilization is a critical public health imperative.
  • Further research and policy development are needed to optimize Medicare's prescription drug benefit.

Related Experiment Videos